Literature DB >> 12716660

Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction.

Leif Breum1, Michael H Rasmussen, Jannik Hilsted, John D Fernstrom.   

Abstract

BACKGROUND: Plasma tryptophan concentrations and the ratio of tryptophan to other large neutral amino acids (plasma tryptophan ratio) are reportedly low in obese subjects. The plasma tryptophan ratio predicts brain tryptophan uptake and serotonin production. If this ratio is low in obese subjects, serotonin function may also be low. Plasma tryptophan concentrations and ratios have been measured only at single time points in obese subjects; it is not known whether low values for these 2 variables persist throughout a 24-h period.
OBJECTIVE: Our objective was to determine whether plasma tryptophan concentrations and ratios in obese subjects are lower than those in normal-weight subjects throughout a 24-h period and whether they increase when body weight is reduced.
DESIGN: Plasma tryptophan concentrations and ratios were examined in obese subjects before and after weight loss and in nonobese control subjects. Blood samples were drawn frequently throughout the 24-h period. An insulin tolerance test was also used to determine whether weight loss altered the ability of insulin to modify plasma concentrations of tryptophan and of the other large neutral amino acids.
RESULTS: Plasma tryptophan concentrations and ratios in obese subjects were low at all times; these effects persisted after weight reduction. Plasma concentrations of all the large neutral amino acids decreased during insulin infusion in all the groups.
CONCLUSIONS: The low 24-h plasma tryptophan ratios in obese and formerly obese subjects suggest that brain tryptophan uptake may be continuously diminished and may remain below normal despite weight reduction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716660     DOI: 10.1093/ajcn/77.5.1112

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  24 in total

1.  The human circadian metabolome.

Authors:  Robert Dallmann; Antoine U Viola; Leila Tarokh; Christian Cajochen; Steven A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-31       Impact factor: 11.205

Review 2.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Non-conventional features of peripheral serotonin signalling - the gut and beyond.

Authors:  Stephanie N Spohn; Gary M Mawe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

4.  Interferon-gamma - Inducible Inflammation: Contribution to Aging and Aging-Associated Psychiatric Disorders.

Authors:  Gregory Oxenkrug
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

5.  Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders.

Authors:  Gregory F Oxenkrug
Journal:  J Neural Transm (Vienna)       Date:  2010-09-02       Impact factor: 3.575

6.  The metabolite profiles of the obese population are gender-dependent.

Authors:  Guoxiang Xie; Xiaojing Ma; Aihua Zhao; Congrong Wang; Yinan Zhang; David Nieman; Jeremy K Nicholson; Wei Jia; Yuqian Bao; Weiping Jia
Journal:  J Proteome Res       Date:  2014-08-26       Impact factor: 4.466

7.  Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis.

Authors:  Justin D Crane; Rengasamy Palanivel; Emilio P Mottillo; Adam L Bujak; Huaqing Wang; Rebecca J Ford; Andrew Collins; Regje M Blümer; Morgan D Fullerton; Julian M Yabut; Janice J Kim; Jean-Eric Ghia; Shereen M Hamza; Katherine M Morrison; Jonathan D Schertzer; Jason R B Dyck; Waliul I Khan; Gregory R Steinberg
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

8.  A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.

Authors:  Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey
Journal:  Cell Metab       Date:  2009-04       Impact factor: 27.287

9.  Diet-induced hyperinsulinemia differentially affects glucose and protein metabolism: a high-throughput metabolomic approach in rats.

Authors:  U Etxeberria; A L de la Garza; J A Martínez; F I Milagro
Journal:  J Physiol Biochem       Date:  2013-01-19       Impact factor: 4.158

10.  Measurement of internal body time by blood metabolomics.

Authors:  Yoichi Minami; Takeya Kasukawa; Yuji Kakazu; Masayuki Iigo; Masahiro Sugimoto; Satsuki Ikeda; Akira Yasui; Gijsbertus T J van der Horst; Tomoyoshi Soga; Hiroki R Ueda
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.